Microbiota and their role in the pathogenesis of oral mucositis

Oral Diseases

Volumn 21, Issue 1, 2015, Pages 17-30

  Vanhoecke, B ^a,b   De Ryck, T ^a   Stringer, A ^b,c   Van de Wiele, T ^a   Keefe, D ^b  

^a GHENT UNIVERSITY   (Belgium)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

Biofilm; Chemotherapy; Microbiota; Mucositis; Oral; Radiotherapy

Indexed keywords

MUCIN; MUCIN 1; MUCIN 19; MUCIN 2; MUCIN 4; MUCIN 5B; MUCIN 7; UNCLASSIFIED DRUG;

ACTINOMYCES; ASPERGILLUS FUMIGATUS; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA TROPICALIS; CAPNOCYTOPHAGA; CHEMOTHERAPY; FUSOBACTERIA; GLYCOSYLATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; KLEBSIELLA PNEUMONIAE; KLUYVEROMYCES MARXIANUS; LACTOBACILLUS BREVIS; LACTOCOCCUS LACTIS; LEPTOTRICHIA; MICROBIAL COLONIZATION; MICROBIAL COMMUNITY; MOUTH FLORA; MOUTH MUCOSA; NEISSERIA; NONHUMAN; ORAL MUCOSITIS; PATHOGENESIS; PICHIA KUDRIAVZEVII; PORPHYROMONAS; PORPHYROMONAS GINGIVALIS; PREVOTELLA; PRIORITY JOURNAL; PROTEUS MIRABILIS; PROTEUS VULGARIS; PSEUDOMONAS AERUGINOSA; RADIOTHERAPY; REVIEW; RISK FACTOR; ROTHIA; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS ANGINOSUS; STREPTOCOCCUS MITIS; STREPTOCOCCUS MUTANS; STREPTOCOCCUS ORALIS; STREPTOCOCCUS SANGUINIS; STREPTOCOCCUS SOBRINUS; TOOTH PLAQUE; TREPONEMA DENTICOLA; VEILLONELLA; MICROBIOLOGY; MICROFLORA; MOUTH; PHYSIOLOGY; STOMATITIS;

HUMANS; MICROBIOTA; MOUTH; MOUTH MUCOSA; RISK FACTORS; STOMATITIS;

EID: 84919446072     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/odi.12224     Document Type: Review

References (119)

1. Aas JA, Paster BJ, Stokes LN, Olsen I, Dewhirst FE (2005). Defining the normal bacterial flora of the oral cavity. J Clin Microbiol 43: 5721-5732.
2. Ahn J, Chen CY, Hayes RB (2012). Oral microbiome and oral and gastrointestinal cancer risk. Cancer Causes Control 23: 399-404.
3. Allen A, Flemström G (2005). Gastroduodenal mucus bicarbonate barrier: protection against acid and pepsin. Am J Physiol Cell Physiol 288: C1-C19.
4. Almståhl A, Wikström M, Fagerberg-Mohlin B (2008). Microflora in oral ecosystems in subjects with radiation-induced hyposalivation. Oral Dis 14: 541-549.
5. Al-Nawas B, Grötz KA (2006). Prospective study of the long term change of the oral flora after radiation therapy. Support Care Cancer 14: 291-296.
6. Amado F, Lobo MJ, Domingues P, Duarte JA, Vitorino R (2010). Salivary peptidomics. Expert Rev Proteomics 7: 709-721.
7. Anirudhan D, Bakhshi S, Xess I, Broor S, Arya LS (2008). Etiology and outcome of oral mucosal lesions in children on chemotherapy for acute lymphoblastic leukemia. Indian Pediatr 45: 47-51.
8. Antunes HS, Ferreira EM, de Faria LM et al (2010). Streptococcal bacteraemia in patients submitted to hematopoietic stem cell transplantation: the role of tooth brushing and use of chlorhexidine. Med Oral Patol Oral Cir Bucal 15: e303-e309.
9. Avila M, Ojcius DM, Yilmaz O (2009). The oral microbiota: living with a permanent guest. DNA Cell Biol 28: 405-411.
10. Ayabe T, Satchell DP, Wilson CL, Parks WC, Selsted ME, Ouellette AJ (2000). Secretion of microbicidal alpha-defensins by intestinal Paneth cells in response to bacteria. Nat Immunol 1: 113-118.
11. Bahri R, Curt S, Saidane-Mosbahi D, Rouabhia M (2010a). Normal human gingival epithelial cells sense C. parapsilosis by toll-like receptors and module its pathogenesis through antimicrobial peptides and proinflammatory cytokines. Mediators Inflamm 2010: 940383.
12. Bahri R, Saidane-Mosbahi D, Rouabhia M (2010b). Candida famata modulates toll-like receptor, beta-defensin, and proinflammatory cytokine expression by normal human epithelial cells. J Cell Physiol 222: 209-218.
13. Beklen A, Sorsa T, Konttinen YT (2009). Toll-like receptors 2 and 5 in human gingival epithelial cells co-operate with T-cell cytokine interleukin-17. Oral Microbiol Immunol 24: 38-42.
14. Belazi M, Velegraki A, Koussidou-Eremondi T et al (2004). Oral Candida isolates in patients undergoing radiotherapy for head and neck cancer: prevalence, azole susceptibility profiles and response to antifungal treatment. Oral Microbiol Immunol 19: 347-351.
15. Bodey GP (1984). Antibiotics in patients with neutropenia. Arch Intern Med 144: 1845-1851.
16. Bodey GP, Buckley M, Sathe YS, Freireich EJ (1966). Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 64: 328-340.
17. Bodey GP, Rodriguez V, Chang H, Narboni G (1978). Fever and infection in leukemic patients. Cancer 41: 1610-1622.
18. Brandão RL, Castro IM, Bambirra EA et al (1998). Intracellular signal triggered by cholera toxin in Saccharomyces boulardii and Saccharomyces cerevisiae. Appl Environ Microbiol 64: 564-568.
19. Brown LR, Dreizen S, Handler S, Johnston DA (1975). Effect of radiation-induced xerostomia on human oral microflora. J Dent Res 54: 740-750.
20. Burdelya LG, Gleiberman AS, Toshkov I et al (2012). Toll-like receptor 5 agonist protects mice from dermatitis and oral mucositis caused by local radiation: implications for head-and-neck cancer radiotherapy. Int J Radiat Oncol Biol Phys 83: 228-234.
21. Burnett GW, Scherp HW (1968). Oral microbiology and infectious disease. The Williams & Wilkins Company: Baltimore, pp. 589.
22. Caluwaerts S, Vandenbroucke K, Steidler L et al (2010). AG013, a mouth rinse formulation of Lactococcus lactis secreting human Trefoil Factor 1, provides a safe and efficacious therapeutic tool for treating oral mucositis. Oral Oncol 46: 564-570.
23. Candoni A, Filì C, Trevisan R, Silvestri F, Fanin R (2003). Fusobacterium nucleatum: a rare cause of bacteremia in neutropenic patients with leukemia and lymphoma. Clin Microbiol Infect 9: 1112-1115.
24. Clarke TB, Davis KM, Lysenko ES, Zhou AY, Yu Y, Weiser JN (2010). Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity. Nat Med 16: 228-231.
25. Collins LM, Dawes C (1987). The surface area of the adult human mouth and thickness of the salivary film covering the teeth and oral mucosa. J Dent Res 66: 1300-1302.
26. Comelli EM, Simmering R, Faure M et al (2008). Multifaceted transcriptional regulation of the murine intestinal mucus layer by endogenous microbiota. Genomics 91: 70-77.
27. Cruz AD, Cogo K, Bergamaschi Cde C, Bóscolo FN, Groppo FC, Almeida SM (2010). Oral streptococci growth on aging and non-aging esthetic restorations after radiotherapy. Braz Dent J 21: 346-350.
28. Czerucka D, Roux I, Rampal P (1994). Saccharomyces boulardii inhibits secretagogue-mediated adenosine 3¢, 5¢-cyclic monophosphate induction in intestinal cells. Gastroenterology 106: 65-72.
29. Deplancke B, Gaskins HR (2001). Microbial modulation of innate defense: goblet cells and the intestinal mucus layer. Am J Clin Nutr 73: 1131S-1141S.
30. Derrien M, van Passel MW, van de Bovenkamp JH, Schipper RG, de Vos WM, Dekker J (2010). Mucin-bacterial interactions in the human oral cavity and digestive tract. Gut Microbes 1: 254-268.
31. Dewhirst FE, Chen T, Izard JJ et al (2010). The human oral microbiome. J Bacteriol 192: 5002-5017.
32. Dreizen S, McCredie KB, Keating MJ, Bodey GP (1982). Oral infections associated with chemotherapy in adults with acute leukemia. Postgrad Med 71: 133-138. 143-146.
33. Ellepola AN, Samaranayake LP (2000). Oral candidal infections and antimycotics. Crit Rev Oral Bio Med 11: 172-198.
34. El-Sayed S, Nabid A, Shelley W et al (2002). Prophylaxis of radiation-associated mucositis in conventionally treated patients with head and neck cancer: a double-blind, phase III, randomized, controlled trial evaluating the clinical efficacy of an antimicrobial lozenge using a validated mucositis scoring system. J Clin Oncol 20: 3956-3963.
35. Epstein JB (2007). Mucositis in the cancer patient and immunosuppressed host. Infect Dis Clin North Am 21: 503-522.
36. Erridge C (2011). Diet, commensals and the intestine as sources of pathogen-associated molecular patterns in atherosclerosis, type 2 diabetes and non-alcoholic fatty liver disease. Atherosclerosis 216: 1-6.
37. Fagundes CT, Amaral FA, Teixeira AL, Souza DG, Teixeira MM (2012). Adapting to environmental stresses: the role of the microbiota in controlling innate immunity and behavioral responses. Immunol Rev 245: 250-264.
38. Ferreira CL, Grześkowiak L, Collado MC, Salminen S (2011). In vitro evaluation of Lactobacillus gasseri strains of infant origin on adhesion and aggregation of specific pathogens. J Food Prot 74: 1482-1487.
39. Forstner JF, Forstner GG (1994). Gastrointestinal mucus. In: Johnson LR, ed. Physiology of the gastrointestinal tract. Raven Press: New York, pp. 1255-1283.
40. Gibson RJ, Bowen JM, Inglis MR, Cummins AG, Keefe DM (2003). Irinotecan causes severe small intestinal damage, as well as colonic damage, in the rat with implanted breast cancer. J Gastroenterol Hepatol 18: 1095-1100.
41. Goodson JM, Groppo D, Halem S, Carpino E (2009). Is obesity an oral bacterial disease? J Dent Res 88: 519-523.
42. Guobis Ž, Kareivien V, Basevičien N et al (2011). Microflora of the oral cavity in patients with xerostomia. Medicina (Kaunas) 47: 646-651.
43. Hu YJ, Shao ZY, Wang Q et al (2013). Exploring the dynamic core microbiome of plaque microbiota during head-and-neck radiotherapy using pyrosequencing. PLoS ONE 8: e56343.
44. Ikuno N, Soda H, Watanabe M, Oka M (1995). Irinotecan (CPT-11) and characteristic mucosal changes in the mouse ileum and cecum. J Natl Cancer Inst 87: 1876-1883.
45. Jenkinson HF, Lamont RJ (2005). Oral microbial communities in sickness and in health. Trends Microbiol 13: 589-595.
46. Junqueira LC, Carneiro J (2005). Basic histology, text and atlas, 11th edn. Appleton & Lange: McGraw Hill, New York, pp. 544.
47. Juntunen M, Kirjavainen PV, Ouwehand AC, Salminen SJ, Isolauri E (2001). Adherence of probiotic bacteria to human intestinal mucus in healthy infants and during rotavirus infection. Clin Diagn Lab Immunol 8: 293-296.
48. Kersun LS, Propert KJ, Lautenbach E, Bunin N, Demichele A (2005). Early bacteremia in pediatric hematopoietic stem cell transplant patients on oral antibiotic prophylaxis. Pediatr Blood Cancer 45: 162-169.
49. Kesimer M, Kiliç N, Mehrotra R, Thornton DJ, Sheehan JK (2009). Identification of salivary mucin MUC7 binding proteins from Streptococcus gordonii. BMC Microbiol 9: 163.
50. Kim Y, Jo AR, da Jang H et al (2012). Toll-like receptor 9 mediates oral bacteria-induced IL-8 expression in gingival epithelial cells. Immunol Cell Biol 90: 655-663.
51. Kocgozlu L, Elkaim R, Tenenbaum H, Werner S (2009). Variable cell responses to P. gingivalis lipopolysaccharide. J Dent Res 88: 741-745.
52. Kolenbrander PE (2000). Oral microbial communities: biofilms, interactions, and genetic systems. Annu Rev Microbiol 54: 413-437.
53. Kolenbrander PE, Palmer RJ Jr, Periasamy S, Jakubovics NS (2010). Oral multispecies biofilm development and the key role of cell-cell distance. Nat Rev Microbiol 8: 471-480.
54. Laheij AM, de Soet JJ, von dem Borne PA et al (2012). Oral bacteria and yeasts in relationship to oral ulcerations in hematopoietic stem cell transplant recipients. Support Care Cancer 20: 3231-3240.
55. Ligtenberg AJ, Walgreen-Weterings E, Veerman EC, de Soet JJ, de Graaff J, Amerongen AV (1992). Influence of saliva on aggregation and adherence of Streptococcus gordonii HG 222. Infect Immun 60: 3878-3884.
56. Lucas KG, Brown AE, Armstrong D, Chapman D, Heller G (1996). The identification of febrile, neutropenic children with neoplastic disease at low risk for bacteremia and complications of sepsis. Cancer 77: 791-798.
57. Mager DL, Ximenez-Fyvie LA, Haffajee AD, Socransky SS (2003). Distribution of selected bacterial species on intraoral surfaces. J Clin Periodontol 30: 644-654.
58. McAuley JL, Linden SK, Png CW et al (2007). MUC1 cell surface mucin is a critical element of the mucosal barrier to infection. J Clin Invest 117: 2313-2324.
59. McGuire DB, Fulton JS, Park J et al (2013). Systematic review of basic oral care for the management of oral mucositis in cancer patients. Support Care Cancer 21: 3165-3177.
60. Meca LB, Souza FR, Tanimoto HM, Castro AL, Gaetti-Jardim Júnior E (2009). Influence of preventive dental treatment on mutans streptococci counts in patients undergoing head and neck radiotherapy. J Appl Oral Sci 17: 5-12.
61. de Mendonça RM, de Araújo M, Levy CE et al (2012). Prospective evaluation of HSV, Candida spp, and oral bacteria on the severity of oral mucositis in pediatric acute lymphoblastic leukemia. Support Care Cancer 20: 1101-1107.
62. Migliorati C, Hewson I, Lalla RV et al (2013). Systematic review of laser and other light therapy for the management of oral mucositis in cancer patients. Support Care Cancer 21: 333-341.
63. Mitchell J (2011). Streptococcus mitis: walking the line between commensalism and pathogenesis. Mol Oral Microbiol 26: 89-98.
64. Mitsuyama M, Ohara R, Amako K, Nomoto K, Yokokura T (1986). Ontogeny of macrophage function to release superoxide anion in conventional and germfree mice. Infect Immun 52: 236-239.
65. Momose Y, Hirayama K, Itoh K (2008). Competition for proline between indigenous Escherichia coli and E. coliO157:H7 in gnotobiotic mice associated with infant intestinal microbiota and its contribution to the colonization resistance against E. coliO157:H7. Antonie Van Leeuwenhoek 94: 165-171.
66. Müller CA, Autenrieth IB, Peschel A (2005). Innate defenses of the intestinal epithelial barrier. Cell Mol Life Sci 62: 1297-1307.
67. Napeñas JJ, Brennan MT, Bahrani-Mougeot FK, Fox PC, Lockhart PB (2007). Relationship between mucositis and changes in oral microflora during cancer chemotherapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 103: 48-59.
68. Napeñas JJ, Brennan MT, Coleman S et al (2010). Molecular methodology to assess the impact of cancer chemotherapy on the oral bacterial flora: a pilot study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 109: 554-560.
69. Nashwan AJ (2011). Use of chlorhexidine mouthwash in children receiving chemotherapy: a review of literature. J Pediatr Oncol Nurs 28: 295-299.
70. Nicolatou-Galitis O, Sarri T, Bowen J et al (2013). Systematic review of amifostine for the management of oral mucositis in cancer patients. Support Care Cancer 21: 357-364.
71. Ohkubo T, Tsuda M, Tamura M, Yamamura M (1990). Impaired superoxide production in peripheral blood neutrophils of germ-free rats. Scand J Immunol 32: 727-729.
72. Okuno SH, Foote RL, Loprinzi CL et al (1997). A randomized trial of a nonabsorbable antibiotic lozenge given to alleviate radiation-induced mucositis. Cancer 79: 2193-2199.
73. Olczak-Kowalczyk D, Daszkiewicz M, Krasuska-Slawińska D-BB et al (2012). Bacteria and Candida yeasts in inflammations of the oral mucosa in children with secondary immunodeficiency. J Oral Pathol Med 41: 568-576.
74. Panghal M, Kaushal V, Kadayan S, Yadav JP (2012). Incidence and risk factors for infection in oral cancer patients undergoing different treatments protocols. BMC Oral Health 12: 22.
75. Peterson DE, Ohrn K, Bowen J et al (2013). Systematic review of oral cryotherapy for management of oral mucositis caused by cancer therapy. Support Care Cancer 21: 327-332.
76. Peyyala R, Ebersole JL (2013). Multispecies biofilms and host responses: "discriminating the trees from the forest". Cytokine 61: 15-25.
77. Ramos MG, Bambirra EA, Nicoli JR, Cara DC, Vieira EC, Alvarez-Leite J (1999). Protection by short-chain fatty acids against 1-beta-D-arabinofuranosylcytosine-induced intestinal lesions in germfree mice. Antimicrob Agents Chemother 43: 950-953.
78. Rand KH, Kramer B, Johnson AC (1982). Cancer chemotherapy associated symptomatic stomatitis: role of Herpes simplex virus (HSV). Cancer 50: 1262-1265.
79. Roberts AP, Mullany P (2010). Oral biofilms: a reservoir of transferable, bacterial, antimicrobial resistance. Expert Rev Anti Infect Ther 8: 1441-1450.
80. Rosan B, Lamont RJ (2000). Dental plaque formation. Microbes Infect 2: 1599-1607.
81. Saunders DP, Epstein JB, Elad S et al (2013). Systematic review of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patients. Support Care Cancer 21: 3191-3207.
82. Schimpff SC (1986). Empiric antibiotic therapy for granulocytopenic cancer patients. Am J Med 80: 13-20.
83. Scully C, el-Kabir M, Samaranayake LP (1994). Candida and oral candidosis: a review. Crit Rev Oral Biol Med 5: 125-157.
84. Segata N, Haake SK, Mannon P et al (2012). Composition of the adult digestive tract bacterial microbiome based on seven mouth surfaces, tonsils, throat and stool samples. Genome Biol 13: R42.
85. Servin AL (2004). Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens. FEMS Microbiol Rev 28: 405-440.
86. Servin AL, Coconnier MH (2003). Adhesion of probiotic strains to the intestinal mucosa and interaction with pathogens. Best Pract Res Clin Gastroenterol 17: 741-754.
87. Shao ZY, Tang ZS, Yan C et al (2011). Effects of intensity-modulated radiotherapy on human oral microflora. J Radiat Res 52: 834-839.
88. Sharma A, Rath GK, Chaudhary SP, Thakar A, Mohanti BK, Bahadur S (2012). Lactobacillus brevis CD2 lozenges reduce radiation- and chemotherapy-induced mucositis in patients with head and neck cancer: a randomized double-blind placebo-controlled study. Eur J Cancer 48: 875-881.
89. Sonalika WG, Amsavardani Tayaar S, Bhat KG, Patil BR, Muddapur MV (2012). Oral microbial carriage in oral squamous cell carcinoma patients at the time of diagnosis and during radiotherapy - a comparative study. Oral Oncol 48: 881-886.
90. Sonis ST (2004). The pathobiology of mucositis. Nat Rev Cancer 4: 277-284.
91. Sonis ST (2009). Mucositis: the impact, biology and therapeutic opportunities of oral mucositis. Oral Oncol 45: 1015-1020.
92. Sonis ST (2010). New thoughts on the initiation of mucositis. Oral Dis 16: 597-600.
93. Spijkervet FK, van Saene HK, van Saene JJ, Panders AK, Vermey A, Mehta DM (1990). Mucositis prevention by selective elimination of oral flora in irradiated head and neck cancer patients. J Oral Pathol Med 19: 486-489.
94. Starling JR, Balish E (1981). Lysosomal enzyme activity in pulmonary alveolar macrophages from conventional, germfree, monoassociated, and conventionalized rats. J Reticuloendothel Soc 30: 497-505.
95. Stokman MA, Spijkervet FK, Burlage FR et al (2003). Oral mucositis and selective elimination of oral flora in head and neck cancer patients receiving radiotherapy: a double-blind randomised clinical trial. Br J Cancer 88: 1012-1016.
96. Straka C, Sandherr M, Salwender H et al (2011). Testing G-CSF responsiveness predicts the individual susceptibility to infection and consecutive treatment in recipients of high-dose chemotherapy. Blood 117: 2121-2128.
97. Stringer AM, Gibson RJ, Bowen JM, Logan RM, Yeoh AS, Keefe DM (2007). Chemotherapy-induced mucositis: the role of gastrointestinal microflora and mucins in the luminal environment. J Support Oncol 5: 259-267.
98. Stringer AM, Gibson RJ, Bowen JM et al (2009a). Irinotecan-induced mucositis manifesting as diarrhoea corresponds with an amended intestinal flora and mucin profile. Int J Exp Pathol 90: 489-499.
99. Stringer AM, Gibson RJ, Logan RM et al (2009b). Gastrointestinal microflora and mucins may play a critical role in the development of 5-Fluorouracil-induced gastrointestinal mucositis. Exp Biol Med (Maywood) 234: 430-441.
100. Stringer AM, Gibson RJ, Logan RM et al (2009c). Irinotecan-induced mucositis is associated with changes in intestinal mucins. Cancer Chemother Pharmacol 64: 123-132.
101. Strober W (2006). Immunology. Unraveling gut inflammation. Science 313: 1052-1054.
102. Strous GJ, Dekker J (1992). Mucin-type glycoproteins. Crit Rev Biochem Mol Biol 27: 57-92.
103. Symonds RP, McIlroy P, Khorrami J et al (1996). The reduction of radiation mucositis by selective decontamination antibiotic pastilles: a placebo-controlled double-blind trial. Br J Cancer 74: 312-317.
104. Tempel TR, Snyderman R, Jordan HV, Mergenhagen SE (1969). Leukocyte chemotactic activity from oral bacteria. J Periodontal Res Suppl 4: 13-14.
105. Terhes G, Piukovics K, Urbán E, Nagy E (2011). Four cases of bacteraemia caused by Fusobacterium nucleatum in febrile, neutropenic patients. J Med Microbiol 60: 1046-1049.
106. Thornton DJ, Sheehan JK (2004). From mucins to mucus: toward a more coherent understanding of this essential barrier. Proc Am Thorac Soc 1: 54-61.
107. Thornton DJ, Khan N, Mehrotra R et al (1999). Salivary mucin MG1 is comprised almost entirely of different glycosylated forms of the MUC5B gene product. Glycobiology 9: 293-302.
108. Thorpe DW, Stringer AM, Gibson RJ (2013). Chemotherapy-induced mucositis: the role of the gastrointestinal microbiome and toll-like receptors. Exp Biol Med (Maywood) 238: 1-6.
109. Tong HC, Gao XJ, Dong XZ (2003). Non-mutans streptococci in patients receiving radiotherapy in the head and neck area. Caries Res 37: 261-266.
110. Verburg M, Renes IB, Meijer HP et al (2000). Selective sparing of goblet cells and paneth cells in the intestine of methotrexate-treated rats. Am J Physiol Gastrointest Liver Physiol 279: G1037-G1047.
111. van Vliet MJ, Tissing WJ, Dun CA et al (2009). Chemotherapy treatment in pediatric patients with acute myeloid leukemia receiving antimicrobial prophylaxis leads to a relative increase of colonization with potentially pathogenic bacteria in the gut. Clin Infect Dis 49: 262-270.
112. van Vliet MJ, Harmsen HJ, de Bont ES, Tissing WJ (2010). The role of intestinal microbiota in the development and severity of chemotherapy-induced mucositis. PLoS Pathog 6: e1000879.
113. Wei GX, Campagna AN, Bobek LA (2006). Effect of MUC7 peptides on the growth of bacteria and on Streptococcus mutans biofilm. J Antimicrob Chemother 57: 1100-1109.
114. Wells MT, Gaffin SL, Jordaan JP (1987). Radiation induced gram negative bacteremia and endotoxemia in rabbits: modification by anti-lipopolysaccharide hyperimmune equine plasma. Life Sci 40: 2543-2550.
115. Wickström C, Svensäter G (2008). Salivary gel-forming mucin MUC5B-a nutrient for dental plaque bacteria. Oral Microbiol Immunol 23: 177-182.
116. Wijers OB, Levendag PC, Harms ER et al (2001). Mucositis reduction by selective elimination of oral flora in irradiated cancers of the head and neck: a placebo-controlled double-blind randomized study. Int J Radiat Oncol Biol Phys 50: 343-352.
117. Wilson M (2005). Microbial inhabitants of humans: their ecology and role in health and disease. N Engl J Med 353: 960-961.
118. Zaura E, Keijser BJ, Huse SM, Crielaard W (2009). Defining the healthy "core microbiome" of oral microbial communities. BMC Microbiol 9: 259.
119. Zur E (2012). Oral mucositis: etiology, and clinical and pharmaceutical management. Int J Pharm Compd 16: 22-33.